BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38218351)

  • 1. Characterization of sessile serrated adenomas with dysplasia including intramucosal adenocarcinoma and colorectal carcinoma with a microsatellite instability phenotype.
    Sugai T; Uesugi N; Osakabe M; Yao T; Yanagawa N; Ajioka Y
    Hum Pathol; 2024 Mar; 145():9-15. PubMed ID: 38218351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.
    Kim KM; Lee EJ; Ha S; Kang SY; Jang KT; Park CK; Kim JY; Kim YH; Chang DK; Odze RD
    Am J Surg Pathol; 2011 Sep; 35(9):1274-86. PubMed ID: 21836485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
    Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
    Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
    Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
    Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal carcinoma occurring via the adenoma-carcinoma pathway in patients with serrated polyposis syndrome.
    Nakamura F; Sato Y; Okamoto K; Fujino Y; Mitsui Y; Kagemoto K; Kawaguchi T; Miyamoto H; Muguruma N; Sonoda T; Tsuneyama K; Takayama T
    J Gastroenterol; 2022 Apr; 57(4):286-299. PubMed ID: 35194694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal serrated adenocarcinoma.
    Mäkinen MJ
    Histopathology; 2007 Jan; 50(1):131-50. PubMed ID: 17204027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis.
    Mezzapesa M; Losurdo G; Celiberto F; Rizzi S; d'Amati A; Piscitelli D; Ierardi E; Di Leo A
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.
    Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T
    Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis.
    Bossard C; Denis MG; Bézieau S; Bach-Ngohou K; Bourreille A; Laboisse CL; Mosnier JF
    Oncol Rep; 2007 Nov; 18(5):1093-7. PubMed ID: 17914558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma.
    Bettington M; Walker N; Rosty C; Brown I; Clouston A; McKeone D; Pearson SA; Leggett B; Whitehall V
    Gut; 2017 Jan; 66(1):97-106. PubMed ID: 26475632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serrated pathway in colorectal carcinogenesis.
    Yamane L; Scapulatempo-Neto C; Reis RM; Guimarães DP
    World J Gastroenterol; 2014 Mar; 20(10):2634-40. PubMed ID: 24627599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic features with associated histological and molecular alterations in serrated polyps with dysplasia: Retrospective analysis of a tertiary case series.
    Trecca A; Borghini R; Medicina D; Del Sordo R; Mandelli G; Bella A; Galloro G; Fu KI; Villanacci V
    Dig Liver Dis; 2024 Apr; 56(4):687-694. PubMed ID: 37778895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.
    Naito T; Nosho K; Ito M; Igarashi H; Mitsuhashi K; Yoshii S; Aoki H; Nomura M; Sukawa Y; Yamamoto E; Adachi Y; Takahashi H; Hosokawa M; Fujita M; Takenouchi T; Maruyama R; Suzuki H; Baba Y; Imai K; Yamamoto H; Ogino S; Shinomura Y
    World J Gastroenterol; 2014 Aug; 20(29):10050-61. PubMed ID: 25110432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis.
    Tsai JH; Liau JY; Lin YL; Lin LI; Cheng YC; Cheng ML; Jeng YM
    Mod Pathol; 2014 Oct; 27(10):1375-85. PubMed ID: 24603588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.
    Rosty C; Buchanan DD; Walsh MD; Pearson SA; Pavluk E; Walters RJ; Clendenning M; Spring KJ; Jenkins MA; Win AK; Hopper JL; Sweet K; Frankel WL; Aronson M; Gallinger S; Goldblatt J; Woodall S; Arnold J; Walker NI; Jass JR; Parry S; Young JP
    Am J Surg Pathol; 2012 Jun; 36(6):876-82. PubMed ID: 22510757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of "sessile serrated" adenoma to carcinoma transition in six early colorectal cancers.
    Cappellesso R; Lo Mele M; Munari G; Rosa-Rizzotto E; Guido E; De Lazzari F; Pilati P; Tonello M; Farinati F; Realdon S; Fassan M; Rugge M
    Pathol Res Pract; 2019 May; 215(5):957-962. PubMed ID: 30738693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
    Kim KM; Lee EJ; Kim YH; Chang DK; Odze RD
    Am J Surg Pathol; 2010 May; 34(5):667-75. PubMed ID: 20305537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.